首页> 外文期刊>Phytotherapy research: PTR >Anticancer activity and molecular mechanisms of alpha-conidendrin, a polyphenolic compound present in Taxus yunnanensis, on human breast cancer cell lines
【24h】

Anticancer activity and molecular mechanisms of alpha-conidendrin, a polyphenolic compound present in Taxus yunnanensis, on human breast cancer cell lines

机译:Alpha-conidendrin的抗癌活性和分子机制,在人乳腺癌细胞系中存在于yunnanensis中的多酚化合物

获取原文
获取原文并翻译 | 示例
           

摘要

alpha-Conidendrin is a polyphenolic compound found mainly in Taxus yunnanensis, as the source of chemotherapy drug paclitaxel, which has been used in traditional medicine for treatment of cancer. This study aimed to investigate the anticancer activity and molecular mechanisms of alpha-conidendrin on breast cancer cell lines. The results of the present study show that alpha-conidendrin possesses potent antiproliferative effects on breast cancer cell lines MCF-7 and MDA-MB-231. alpha-Conidendrin significantly induced apoptosis in breast cancer cells via reactive oxygen species generation, upregulation of p53 and Bax, downregulation of Bcl-2, depolarization of mitochondrial membrane potential (MMP), release of cytochrome c from mitochondria, and activation of caspases-3 and -9. alpha-Conidendrin remarkably inhibited the proliferation of breast cancer cells through induction of cell cycle arrest by upregulating p53 and p21 and downregulating cyclin D1 and CDK4. Unlike breast cancer cells, the antiproliferative effect of alpha-conidendrin on human foreskin fibroblast cells (normal cells) was very small. In normal cells, reactive oxygen species levels, loss of MMP, release of cytochrome c, mRNA expression of p53, p21, cyclin D1, CDK4, Bax, and Bcl-2 as well as mRNA expression and activity of caspases-3 and -9 were significantly less affected by alpha-conidendrin compared with cancer cells. These results suggest that alpha-conidendrin can be a promising agent for treatment of breast cancer with little or no toxicity against normal cells.
机译:Alpha-conidendrin是一种主要在Taxus yunnanensis中的多酚化合物,作为化疗药物紫杉醇的来源,该紫杉醇已被用于传统医学用于治疗癌症。本研究旨在探讨α-康纳丹蛋白对乳腺癌细胞系的抗癌活性和分子机制。本研究的结果表明,α-康丹林对乳腺癌细胞系MCF-7和MDA-MB-231具有有效的抗增殖作用。 Alpha-Conidendrin通过反应性氧物质产生显着诱导乳腺癌细胞的凋亡,P53和Bax的上调,Bcl-2的下调,线粒体膜电位(MMP)的去极化,从线粒体释放细胞色素C,并激活Caspases-3和-9。通过上调P53和P21和下调细胞周期蛋白D1和CDK4,通过诱导细胞周期停滞,显着抑制乳腺癌细胞的增殖。与乳腺癌细胞不同,α-Conidendrin对人包皮细胞(正常细胞)的抗增殖作用非常小。在正常细胞中,活性氧物质水平,MMP丧失,细胞色素C的释放,P53,P21,细胞周期蛋白D1,CDK4,BAX和BCL-2的MRNA表达以及Caspases-3和-9的mRNA表达和活性与癌细胞相比,受α-conidendrin的影响显着较小。这些结果表明,α-conidendrin可以是用于治疗乳腺癌的有希望的药物,对正常细胞很少或没有毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号